FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

13867311000001105: Orphenadrine 50mg tablets 50 tablet (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Apr 2009. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
49814701000001118 Orphenadrine 50mg tablets 50 tablet (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
49814801000001110 Orphenadrine 50mg tablets 50 tablet en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


3 descendants. Search Descendants:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Orphenadrine 50mg tablets 50 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Orphenadrine 50mg tablets 50 tablet Has VMP Orphenadrine 50mg tablets true Inferred relationship Existential restriction modifier
Orphenadrine 50mg tablets 50 tablet Has VMP Orphenadrine 50mg tablets false Inferred relationship Existential restriction modifier
Orphenadrine 50mg tablets 50 tablet Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Orphenadrine 50mg tablets 50 tablet Is pack of Product containing precisely orphenadrine 50 milligram/1 each conventional release oral tablet false Inferred relationship Existential restriction modifier
Orphenadrine 50mg tablets 50 tablet Has active ingredient Orphenadrine false Inferred relationship Existential restriction modifier
Orphenadrine 50mg tablets 50 tablet Has active ingredient Orphenadrine hydrochloride false Inferred relationship Existential restriction modifier
Orphenadrine 50mg tablets 50 tablet Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier
Orphenadrine 50mg tablets 50 tablet Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
Orphenadrine 50mg tablets 50 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Orphenadrine 50mg tablets 50 tablet VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
Orphenadrine 50mg tablets 50 tablet Has VMP Product containing precisely orphenadrine 50 milligram/1 each conventional release oral tablet false Inferred relationship Existential restriction modifier
Orphenadrine 50mg tablets 50 tablet Has specific active ingredient Orphenadrine hydrochloride true Inferred relationship Existential restriction modifier
Orphenadrine 50mg tablets 50 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Orphenadrine 50mg tablets 50 tablet VMP non-availability indicator Not available false Inferred relationship Existential restriction modifier
Orphenadrine 50mg tablets 50 tablet VMP non-availability indicator Re-introduced true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Disipal 50mg tablets (Doncaster Pharmaceuticals Ltd) 50 tablet Is a True Orphenadrine 50mg tablets 50 tablet Inferred relationship Existential restriction modifier
Disipal 50mg tablets (Stephar (U.K.) Ltd) 50 tablet Is a True Orphenadrine 50mg tablets 50 tablet Inferred relationship Existential restriction modifier
Disipal 50mg tablets (Mawdsley-Brooks & Company Ltd) 50 tablet Is a True Orphenadrine 50mg tablets 50 tablet Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start